Aster DM Quality Care Limited has scheduled an earnings conference call with analysts and investors for Wednesday, 5 August 2026, at 6:00 PM IST. The session aims to discuss the company’s unaudited financial results for the quarter ended 30 June 2026, offering stakeholders direct access to management commentary on the latest performance metrics.

The disclosure was made in compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice was issued by Hemish Purushottam, Company Secretary and Compliance Officer of Aster DM Quality Care Limited, and filed with both BSE Limited and The National Stock Exchange of India Limited on 31 July 2026.

Conference Call Details

The earnings call will feature key executives from Aster DM Quality Care who will address questions regarding the company's operational and financial standing for Q1FY27. Participants can register via the provided link or contact the investor relations team for further clarification.

Key Information

Investors are advised to note the specific timing and registration requirements to participate in the live discussion. The event serves as a critical platform for understanding the drivers behind the quarterly figures before their formal publication.

• Date: Wednesday, 5 August 2026
• Time: 6:00 PM IST
• Topic: Unaudited Financial Results for Quarter Ended 30 June 2026
• Registration: Available via the official investor portal

For additional queries, investors may email investors@asterqualitycare.com .

The National Stock Exchange of India Limited (NSE) has confirmed that aster dm healthcare will change its corporate name to Aster DM Quality Care Limited effective July 28, 2026. This renaming action reflects a strategic shift in the company’s branding identity while maintaining continuity in its market presence. The change applies to the entity currently listed under the name Aster DM Healthcare Limited.

Change in Corporate Name

The NSE issued Circular Ref. No. 1200/2026 on July 22, 2026, notifying all exchange members of the impending name change. The circular states that the new name will be effective w.e.f. July 28, 2026. This procedural update ensures that all trading, settlement, and corporate actions are aligned with the new nomenclature from the specified date.

Trading Symbol Continuity

Despite the change in the corporate name, the trading symbol for the company remains unchanged. This ensures that existing investors and traders do not need to adjust their portfolios or trading systems regarding the ticker identifier. The details of the change are outlined below:

The existing symbol "ASTERDM" will continue to be used for trading purposes. The new name, Aster DM Quality Care Limited, will replace the previous name in all official records and disclosures starting from the effective date.

Regulatory Compliance

The name change is subject to regulatory approvals and compliance with the listing regulations of the NSE. The circular serves as an official notification to the market participants, ensuring transparency and timely dissemination of information. Investors are advised to note the effective date for any future correspondence or documentation related to the company.

What the Numbers Show

While this announcement is primarily administrative, it signals a potential rebranding effort by the management. The retention of the trading symbol suggests that the core business operations and market perception remain stable during this transition. The effective date of July 28, 2026, provides a clear timeline for stakeholders to update their records.